-
Nareen
Abboud,
Siu-Kei
Chow,
Carolyn
Saylor,
A.
Janda,
Jeffery
Ravetch,
M.
Scharff,
A.
Casadevall
(2010)
A requirement for FcγR in antibody-mediated bacterial toxin neutralization
The Journal of Experimental Medicine, 207
-
Musa
Sani,
A.
Botteaux,
C.
Parsot,
P.
Sansonetti,
E.
Boekema,
A.
Allaoui
(2007)
IpaD is localized at the tip of the Shigella flexneri type III secretion apparatus.
Biochimica et biophysica acta, 1770 2
-
Jeffrey
Froude,
B.
Stiles,
Thibaut
Pelat,
P.
Thullier
(2011)
Antibodies for biodefense
mAbs, 3
-
M.
Espina,
Andrew
Olive,
R.
Kenjale,
D.
Moore,
S.
Ausar,
R.
Kaminski,
E.
Oaks,
C.
Middaugh,
W.
Picking,
W.
Picking
(2006)
IpaD Localizes to the Tip of the Type III Secretion System Needle of Shigella flexneri
Infection and Immunity, 74
-
D.
Frank,
A.
Vallis,
J.
Wiener‐Kronish,
A.
Roy‐Burman,
E.
Spack,
B.
Mullaney,
Mehdi
Megdoud,
J.
Marks,
R.
Fritz,
T.
Sawa
(2002)
Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.
The Journal of infectious diseases, 186 1
-
C.
Pujol,
J.
Bliska
(2003)
The Ability To Replicate in Macrophages Is Conserved between Yersinia pestis and Yersinia pseudotuberculosis
Infection and Immunity, 71
-
Lisa
Runco,
Selina
Myrczek,
J.
Bliska,
D.
Thanassi
(2008)
Biogenesis of the Fraction 1 Capsule and Analysis of the Ultrastructure of Yersinia pestis
Journal of Bacteriology, 190
-
T.
Inglesby,
D.
Dennis,
D.
Henderson,
J.
Bartlett,
M.
Ascher,
E.
Eitzen,
Anne
Fine,
A.
Friedlander,
J.
Hauer,
John
Koerner,
Marcelle
Layton,
Joseph
McDade,
M.
Osterholm,
T.
O'Toole,
Gerald
Parker,
T.
Perl,
Philip
Russell,
M.
Schoch-Spana,
K.
Tonat
(2000)
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
JAMA, 283 17
-
Nicholas
Eisele,
Deborah
Anderson
(2009)
Dual-Function Antibodies to Yersinia pestis LcrV Required for Pulmonary Clearance of Plague
Clinical and Vaccine Immunology, 16
-
F.
Nimmerjahn,
J.
Ravetch
(2005)
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Science, 310
-
K.
Fields,
Matthew
Nilles,
C.
Cowan,
S.
Straley
(1999)
Virulence Role of V Antigen of Yersinia pestis at the Bacterial Surface
Infection and Immunity, 67
-
C.
Sofer-Podesta,
J.
Ang,
N.
Hackett,
S.
Senina,
D.
Perlin,
R.
Crystal,
J.
Boyer
(2009)
Adenovirus-Mediated Delivery of an Anti-V Antigen Monoclonal Antibody Protects Mice against a Lethal Yersinia pestis Challenge
Infection and Immunity, 77
-
G.
Viboud,
J.
Bliska
(2002)
Measurement of pore formation by contact-dependent type III protein secretion systems.
Methods in enzymology, 358
-
L.
Palmer,
A.
Pancetti,
S.
Greenberg,
J.
Bliska
(1999)
YopJ of Yersinia spp. Is Sufficient To Cause Downregulation of Multiple Mitogen-Activated Protein Kinases in Eukaryotic Cells
Infection and Immunity, 67
-
Su
Hua,
J.
Spangrude,
H.
Caldwell
Expression of FcyRIII on HeLa 229 Cells : Possible Effect on In Vitro Neutralization of Chlamydia trachomatis
-
Xiaodong
Xiao,
Zhongyu
Zhu,
Jennifer
Dankmeyer,
Michael
Wormald,
R.
Fast,
P.
Worsham,
C.
Cote,
K.
Amemiya,
D.
Dimitrov
(2010)
Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model
PLoS ONE, 5
-
H.
Su,
G.
Spangrude,
H.
Caldwell
(1991)
Expression of Fc gamma RIII on HeLa 229 cells: possible effect on in vitro neutralization of Chlamydia trachomatis
Infection and Immunity, 59
-
R.
Titball,
Diane
Williamson
(2004)
Yersinia pestis (plague) vaccines
Expert Opinion on Biological Therapy, 4
-
R.
Brubaker
(2003)
Interleukin-10 and Inhibition of Innate Immunity to Yersiniae: Roles of Yops and LcrV (V Antigen)
Infection and Immunity, 71
-
J.
Pettersson,
A.
Holmström,
Jim
Hill,
S.
Leary,
E.
Frithz‐Lindsten,
Anne
Euler‐Matell,
E.
Carlsson,
R.
Titball,
A.
Forsberg,
H.
Wolf‐Watz
(1999)
The V‐antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation
Molecular Microbiology, 32
-
Jim
Hill,
J.
Eyles,
S.
Elvin,
Gareth
Healey,
R.
Lukaszewski,
R.
Titball
(2006)
Administration of Antibody to the Lung Protects Mice against Pneumonic Plague
Infection and Immunity, 74
-
Lauriane
Quenee,
Bryan
Berube,
Joshua
Segal,
D.
Elli,
N.
Ciletti,
Deborah
Anderson,
O.
Schneewind
(2010)
Amino acid residues 196-225 of LcrV represent a plague protective epitope.
Vaccine, 28 7
-
Jim
Hill,
S.
Leary,
S.
Smither,
A.
Best,
J.
Pettersson,
A.
Forsberg,
B.
Lingard,
Alexandria
Lipka,
Katherine
Brown,
E.
Williamson,
R.
Titball
(2009)
N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection.
Vaccine, 27 50
-
Julien
Gouré,
P.
Brož,
O.
Attrée,
G.
Cornelis,
I.
Attrée
(2005)
Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes.
The Journal of infectious diseases, 192 2
-
U.
Derewenda,
A.
Mateja,
Y.
Devedjiev,
K.
Routzahn,
A.
Evdokimov,
Z.
Derewenda,
D.
Waugh
(2004)
The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague.
Structure, 12 2
-
Sarit
Lilo,
Ying
Zheng,
J.
Bliska
(2008)
Caspase-1 Activation in Macrophages Infected with Yersinia pestis KIM Requires the Type III Secretion System Effector YopJ
Infection and Immunity, 76
-
Hiromi
Sato,
D.
Frank
(2011)
Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria
Frontiers in Microbiology, 2
-
T.
Sawa,
T.
Yahr,
M.
Ohara,
K.
Kurahashi,
M.
Gropper,
J.
Wiener‐Kronish,
D.
Frank
(1999)
Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury
Nature Medicine, 5
-
D.
Thanassi,
J.
Bliska,
P.
Christie
(2012)
Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.
FEMS microbiology reviews, 36 6
-
J.
Hill,
S.
Leary,
K.
Griffin,
E.
Williamson,
R.
Titball
(1997)
Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization
Infection and Immunity, 65
-
Thomas
Inglesby,
Donald
Henderson,
J.
Bartlett,
M.
Ascher,
E.
Eitzen,
Arthur
Friedlander,
J.
Hauer,
Joseph
McDade,
Michael
Osterholm,
T.
O'Toole,
Gerald
Parker,
T.
Perl,
Philip
Russell,
K.
Tonat
(1999)
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
JAMA, 281 18
-
S.
Smiley
(2008)
Immune defense against pneumonic plague
Immunological Reviews, 225
-
C.
Cowan,
A.
Philipovskiy,
C.
Wulff-Strobel,
Zhan
Ye,
S.
Straley
(2005)
Anti-LcrV Antibody Inhibits Delivery of Yops by Yersinia pestis KIM5 by Directly Promoting Phagocytosis
Infection and Immunity, 73
-
J.
Deane,
P.
Roversi,
F.
Cordes,
Steven
Johnson,
R.
Kenjale,
S.
Daniell,
Frank
Booy,
W.
Picking,
W.
Picking,
A.
Blocker,
S.
Lea
(2006)
Molecular model of a type III secretion system needle: Implications for host-cell sensing
Proceedings of the National Academy of Sciences, 103
-
E.
Mejía,
J.
Bliska,
G.
Viboud
(2008)
Yersinia Controls Type III Effector Delivery into Host Cells by Modulating Rho Activity
PLoS Pathogens, 4
-
S.
Weeks,
J.
Hill,
A.
Friedlander,
S.
Welkos
(2002)
Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis.
Microbial pathogenesis, 32 5
-
F.
Nimmerjahn,
J.
Ravetch
(2008)
Fcγ receptors as regulators of immune responses
Nature Reviews Immunology, 8
-
R.
Perry,
Jacqueline
Fetherston
(1997)
Yersinia pestis--etiologic agent of plague
Clinical Microbiology Reviews, 10
-
C.
Mueller,
P.
Brož,
G.
Cornelis
(2008)
The type III secretion system tip complex and translocon
Molecular Microbiology, 68
-
Jr-Shiuan
Lin,
Steven
Park,
J.
Adamovicz,
Jim
Hill,
J.
Bliska,
C.
Cote,
D.
Perlin,
K.
Amemiya,
S.
Smiley
(2010)
TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.
Vaccine, 29 2
-
Prentice
(2007)
Plague
Lancet, 369
-
B.
Noel,
Sarit
Lilo,
D.
Capurso,
Jim
Hill,
J.
Bliska
(2009)
Yersinia pestis Can Bypass Protective Antibodies to LcrV and Activation with Gamma Interferon To Survive and Induce Apoptosis in Murine Macrophages
Clinical and Vaccine Immunology, 16
-
Claire
Vernazza,
B.
Lingard,
H.
Flick-Smith,
L.
Baillie,
Jim
Hill,
H.
Atkins
(2009)
Small protective fragments of the Yersinia pestis V antigen.
Vaccine, 27 21
-
P.
Brož,
C.
Mueller,
S.
Müller,
A.
Philippsen,
I.
Sorg,
A.
Engel,
G.
Cornelis
(2007)
Function and molecular architecture of the Yersinia injectisome tip complex
Molecular Microbiology, 65
-
G.
Cornelis
(2006)
The type III secretion injectisome
Nature Reviews Microbiology, 4
-
Jim
Hill,
Catherine
Copse,
S.
Leary,
A.
Stagg,
E.
Williamson,
R.
Titball
(2003)
Synergistic Protection of Mice against Plague with Monoclonal Antibodies Specific for the F1 and V Antigens of Yersinia pestis
Infection and Immunity, 71
-
C.
Mueller,
P.
Brož,
S.
Müller,
P.
Ringler,
Françoise
Erne-Brand,
I.
Sorg,
Marina
Kuhn,
A.
Engel,
G.
Cornelis
(2005)
The V-Antigen of Yersinia Forms a Distinct Structure at the Tip of Injectisome Needles
Science, 310
-
T.
Desin,
C.
Mickael,
Po-King
Lam,
A.
Potter,
W.
Köster
(2010)
Protection of epithelial cells from Salmonella enterica serovar Enteritidis invasion by antibodies against the SPI-1 type III secretion system.
Canadian journal of microbiology, 56 6
-
M.
Gomes-Solecki,
Anne
Savitt,
R.
Rowehl,
J.
Glass,
J.
Bliska,
R.
Dattwyler
(2005)
LcrV Capture Enzyme-Linked Immunosorbent Assay for Detection of Yersinia pestis from Human Samples
Clinical and Vaccine Immunology, 12